Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP892469.RA0K09sRAFapKzhPVaixfVk_TLWgnz6XhkfGasZ5iSZm0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP892469.RA0K09sRAFapKzhPVaixfVk_TLWgnz6XhkfGasZ5iSZm0130_assertion type Assertion NP892469.RA0K09sRAFapKzhPVaixfVk_TLWgnz6XhkfGasZ5iSZm0130_head.
- NP892469.RA0K09sRAFapKzhPVaixfVk_TLWgnz6XhkfGasZ5iSZm0130_assertion description "[These cells grew slowly and were expanded over a period of 3 years and have maintained characteristics consistent with those of both the original ASPS tumor from the patient and the xenograft tumor including (1) presence of the alveolar soft part locus-transcription factor E3 type 1 fusion transcript and nuclear expression of the alveolar soft part locus-transcription factor E3 type 1 fusion protein; (2) maintenance of the t(X;17)(p11;q25) translocation characteristic of ASPS; and (3) expression of upregulated ASPS transcripts involved in angiogenesis (ANGPTL2, HIF-1-?, MDK, c-MET, VEGF, and TIMP-2), cell proliferation (PRL, PCSK1), metastasis (ADAM9), as well as the transcription factor BHLHB3 and the muscle-specific transcripts TRIM63 and ITG?1BP3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892469.RA0K09sRAFapKzhPVaixfVk_TLWgnz6XhkfGasZ5iSZm0130_provenance.
- NP892469.RA0K09sRAFapKzhPVaixfVk_TLWgnz6XhkfGasZ5iSZm0130_assertion evidence source_evidence_literature NP892469.RA0K09sRAFapKzhPVaixfVk_TLWgnz6XhkfGasZ5iSZm0130_provenance.
- NP892469.RA0K09sRAFapKzhPVaixfVk_TLWgnz6XhkfGasZ5iSZm0130_assertion SIO_000772 21552147 NP892469.RA0K09sRAFapKzhPVaixfVk_TLWgnz6XhkfGasZ5iSZm0130_provenance.
- NP892469.RA0K09sRAFapKzhPVaixfVk_TLWgnz6XhkfGasZ5iSZm0130_assertion wasDerivedFrom befree-2016 NP892469.RA0K09sRAFapKzhPVaixfVk_TLWgnz6XhkfGasZ5iSZm0130_provenance.
- NP892469.RA0K09sRAFapKzhPVaixfVk_TLWgnz6XhkfGasZ5iSZm0130_assertion wasGeneratedBy ECO_0000203 NP892469.RA0K09sRAFapKzhPVaixfVk_TLWgnz6XhkfGasZ5iSZm0130_provenance.